Promaxo Inc. of Oakland, Calif., sold eight of its systems for performing AI-equipped, MRI-guided prostate interventions in the fourth quarter of 2022. The company launched a year prior and has now topped $15 million in sales.
Welcome to Movers & Shakers, a roundup of the latest executive movements in healthcare, featuring leadership appointments from the Centers for Disease Control and Prevention (CDC) and Mass Eye and Ear.
Segmentation results of the three spatial axes for the initial and final time images of each patient. Image courtesy of the Journal of Theoretical Biology.
Researchers from the University of Waterloo and the University of Toronto are collaborating to better understand how glioblastoma multiforme (GBM) advances when it is not treated.
"These findings provide further insight into the positive effects of the DASH diet ... and highlight the need for public health policies and interventions that support sustained adherence to a healthy eating pattern," researchers wrote.
Researchers evaluated if two recently developed risk scores can anticipate adverse in-hospital outcomes after PCI, sharing their findings in the American Journal of Cardiology.